Theratechnologies Average Payables vs Price To Sales Ratio Analysis

TH Stock

CAD 1.67 0.01 0.60%

Theratechnologies financial indicator trend analysis is much more than just breaking down Theratechnologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theratechnologies is a good investment. Please check the relationship between Theratechnologies Average Payables and its Price To Sales Ratio accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.

Average Payables vs Price To Sales Ratio

Average Payables vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Theratechnologies Average Payables account and Price To Sales Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Theratechnologies' Average Payables and Price To Sales Ratio is -0.21. Overlapping area represents the amount of variation of Average Payables that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Theratechnologies, assuming nothing else is changed. The correlation between historical values of Theratechnologies' Average Payables and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Average Payables of Theratechnologies are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Average Payables i.e., Theratechnologies' Average Payables and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.21

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Theratechnologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Theratechnologies sales, a figure that is much harder to manipulate than other Theratechnologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Theratechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Selling General Administrative is very stable compared to the past year. As of the 23rd of November 2024, Tax Provision is likely to grow to about 508.4 K, while Issuance Of Capital Stock is likely to drop about 16.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	53.8M	62.1M	71.4M	75.0M
Total Revenue	80.1M	81.8M	94.0M	98.7M

Gross Profit Total Revenue

Theratechnologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Liab	Short Term Investments
Total Assets		0.89	0.63	-0.1	0.42	0.79	-0.57	0.94	0.68	0.79	0.06	0.51	0.83	0.77	0.47	0.75	0.67	0.79	0.32	0.84	0.45	0.94	0.29	0.77	0.7	0.49
Short Long Term Debt Total	0.89		0.75	-0.44	0.5	0.85	-0.72	0.79	0.77	0.58	0.05	0.67	0.81	0.78	0.25	0.74	0.56	0.71	0.43	0.9	0.58	0.89	0.45	0.64	0.84	0.21
Total Current Liabilities	0.63	0.75		-0.68	0.58	0.84	-0.71	0.6	0.61	0.31	-0.03	0.81	0.66	0.76	0.33	0.35	0.39	0.69	0.53	0.84	0.71	0.75	0.81	0.35	0.86	0.26
Total Stockholder Equity	-0.1	-0.44	-0.68		-0.54	-0.59	0.59	-0.07	-0.49	0.23	0.22	-0.79	-0.37	-0.57	0.32	-0.28	0.09	-0.23	-0.6	-0.6	-0.73	-0.35	-0.47	0.07	-0.75	0.16
Property Plant And Equipment Net	0.42	0.5	0.58	-0.54		0.74	-0.22	0.57	0.29	0.05	-0.48	0.41	0.33	0.51	-0.03	0.33	0.46	0.65	0.79	0.56	0.94	0.5	0.33	0.26	0.58	0.44
Net Debt	0.79	0.85	0.84	-0.59	0.74		-0.73	0.79	0.62	0.52	-0.29	0.73	0.7	0.85	0.31	0.67	0.63	0.8	0.56	0.93	0.82	0.86	0.46	0.56	0.9	0.32
Retained Earnings	-0.57	-0.72	-0.71	0.59	-0.22	-0.73		-0.4	-0.54	-0.35	0.06	-0.74	-0.58	-0.66	-0.28	-0.54	-0.38	-0.55	-0.13	-0.76	-0.43	-0.66	-0.4	-0.33	-0.79	0.11
Accounts Payable	0.94	0.79	0.6	-0.07	0.57	0.79	-0.4		0.56	0.76	-0.15	0.38	0.7	0.7	0.51	0.66	0.73	0.79	0.36	0.76	0.52	0.86	0.27	0.74	0.6	0.53
Cash	0.68	0.77	0.61	-0.49	0.29	0.62	-0.54	0.56		0.45	0.32	0.81	0.95	0.85	-0.09	0.8	0.06	0.36	0.55	0.85	0.5	0.83	0.24	0.31	0.81	0.24
Non Current Assets Total	0.79	0.58	0.31	0.23	0.05	0.52	-0.35	0.76	0.45		0.01	0.23	0.59	0.54	0.6	0.64	0.6	0.44	-0.04	0.56	0.05	0.68	0.07	0.77	0.38	0.34
Non Currrent Assets Other	0.06	0.05	-0.03	0.22	-0.48	-0.29	0.06	-0.15	0.32	0.01		0.07	0.3	-0.08	-0.04	-0.04	-0.32	-0.14	-0.06	-0.04	-0.35	0.08	0.15	-0.18	-0.06	0.09
Other Assets	0.51	0.67	0.81	-0.79	0.41	0.73	-0.74	0.38	0.81	0.23	0.07		0.8	0.89	-0.12	0.58	-0.01	0.37	0.63	0.85	0.67	0.72	0.46	0.18	0.91	0.17
Cash And Short Term Investments	0.83	0.81	0.66	-0.37	0.33	0.7	-0.58	0.7	0.95	0.59	0.3	0.8		0.9	0.09	0.82	0.23	0.54	0.53	0.9	0.52	0.93	0.25	0.48	0.83	0.45
Net Receivables	0.77	0.78	0.76	-0.57	0.51	0.85	-0.66	0.7	0.85	0.54	-0.08	0.89	0.9		0.07	0.8	0.26	0.55	0.62	0.95	0.69	0.9	0.3	0.52	0.91	0.39
Common Stock Shares Outstanding	0.47	0.25	0.33	0.32	-0.03	0.31	-0.28	0.51	-0.09	0.6	-0.04	-0.12	0.09	0.07		0.0	0.76	0.58	-0.42	0.21	-0.11	0.34	0.37	0.5	0.08	0.21
Non Current Liabilities Total	0.75	0.74	0.35	-0.28	0.33	0.67	-0.54	0.66	0.8	0.64	-0.04	0.58	0.82	0.8	0.0		0.35	0.45	0.38	0.8	0.46	0.82	-0.16	0.59	0.73	0.28
Inventory	0.67	0.56	0.39	0.09	0.46	0.63	-0.38	0.73	0.06	0.6	-0.32	-0.01	0.23	0.26	0.76	0.35		0.83	-0.04	0.45	0.34	0.55	0.25	0.67	0.34	0.31
Other Current Assets	0.79	0.71	0.69	-0.23	0.65	0.8	-0.55	0.79	0.36	0.44	-0.14	0.37	0.54	0.55	0.58	0.45	0.83		0.33	0.7	0.64	0.77	0.42	0.57	0.64	0.53
Other Stockholder Equity	0.32	0.43	0.53	-0.6	0.79	0.56	-0.13	0.36	0.55	-0.04	-0.06	0.63	0.53	0.62	-0.42	0.38	-0.04	0.33		0.56	0.85	0.49	0.29	0.08	0.61	0.5
Total Liab	0.84	0.9	0.84	-0.6	0.56	0.93	-0.76	0.76	0.85	0.56	-0.04	0.85	0.9	0.95	0.21	0.8	0.45	0.7	0.56		0.72	0.95	0.43	0.57	0.97	0.33
Property Plant And Equipment Gross	0.45	0.58	0.71	-0.73	0.94	0.82	-0.43	0.52	0.5	0.05	-0.35	0.67	0.52	0.69	-0.11	0.46	0.34	0.64	0.85	0.72		0.62	0.37	0.2	0.78	0.4
Total Current Assets	0.94	0.89	0.75	-0.35	0.5	0.86	-0.66	0.86	0.83	0.68	0.08	0.72	0.93	0.9	0.34	0.82	0.55	0.77	0.49	0.95	0.62		0.33	0.64	0.87	0.5
Short Term Debt	0.29	0.45	0.81	-0.47	0.33	0.46	-0.4	0.27	0.24	0.07	0.15	0.46	0.25	0.3	0.37	-0.16	0.25	0.42	0.29	0.43	0.37	0.33		0.17	0.46	0.06
Intangible Assets	0.77	0.64	0.35	0.07	0.26	0.56	-0.33	0.74	0.31	0.77	-0.18	0.18	0.48	0.52	0.5	0.59	0.67	0.57	0.08	0.57	0.2	0.64	0.17		0.44	0.42
Other Current Liab	0.7	0.84	0.86	-0.75	0.58	0.9	-0.79	0.6	0.81	0.38	-0.06	0.91	0.83	0.91	0.08	0.73	0.34	0.64	0.61	0.97	0.78	0.87	0.46	0.44		0.26
Short Term Investments	0.49	0.21	0.26	0.16	0.44	0.32	0.11	0.53	0.24	0.34	0.09	0.17	0.45	0.39	0.21	0.28	0.31	0.53	0.5	0.33	0.4	0.5	0.06	0.42	0.26

Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	100.1M	119.2M	93.3M	77.8M	89.4M	65.2M
Short Long Term Debt Total	55.4M	56.7M	66.7M	59.0M	67.8M	38.1M
Total Current Liabilities	41.9M	45.1M	114.3M	47.3M	54.4M	57.1M
Total Stockholder Equity	3.2M	17.8M	(22.6M)	(20.9M)	(18.8M)	(17.8M)
Property Plant And Equipment Net	3.5M	2.9M	3.1M	2.0M	1.8M	1.3M
Net Debt	42.6M	36.3M	42.9M	24.9M	28.6M	30.0M
Retained Earnings	(300.1M)	(335.2M)	(382.6M)	(408.7M)	(367.8M)	(349.4M)
Accounts Payable	17.5M	15.5M	12.9M	7.0M	8.0M	6.4M
Cash	12.7M	20.4M	23.9M	34.1M	39.2M	41.2M
Non Current Assets Total	35.3M	27.3M	19.9M	14.5M	16.6M	29.9M
Non Currrent Assets Other	12.2M	(35.3M)	621K	1.8M	1.6M	1.5M
Cash And Short Term Investments	20.8M	40.4M	33.1M	40.4M	46.4M	48.8M
Net Receivables	13.2M	10.9M	12.3M	13.6M	15.6M	16.4M
Common Stock Shares Outstanding	77.0M	92.4M	95.3M	26.3M	30.3M	55.9M
Liabilities And Stockholders Equity	100.1M	119.2M	93.3M	77.8M	89.4M	65.2M
Non Current Liabilities Total	55.0M	56.4M	1.6M	51.3M	59.0M	62.0M
Inventory	25.1M	29.1M	19.7M	6.1M	7.0M	7.8M
Other Current Assets	5.7M	11.5M	8.3M	3.3M	3.8M	2.0M
Other Stockholder Equity	16.5M	17.3M	20.9M	23.2M	20.9M	19.8M
Total Liab	96.9M	101.5M	115.8M	98.6M	113.4M	119.1M
Property Plant And Equipment Gross	3.5M	3.6M	3.9M	3.2M	2.9M	3.0M
Total Current Assets	64.8M	91.9M	73.4M	63.3M	72.8M	76.4M
Accumulated Other Comprehensive Income	(481K)	(44K)	385K	684K	786.6K	825.9K
Short Term Debt	425K	463K	65.3M	7.7M	8.9M	8.8M
Intangible Assets	31.9M	23.8M	15.0M	12.5M	14.4M	12.3M
Other Current Liab	23.9M	29.0M	36.1M	32.6M	37.4M	39.3M
Short Term Investments	8.0M	20.0M	9.2M	6.3M	5.7M	9.9M
Current Deferred Revenue	70K	50K	54K	38K	34.2K	32.5K
Net Tangible Assets	(14.9M)	(28.6M)	(6.1M)	(37.6M)	(33.8M)	(32.1M)
Common Stock	287.3M	335.8M	338.8M	363.9M	418.5M	306.6M
Property Plant Equipment	1.1M	3.5M	2.9M	3.1M	3.6M	3.7M
Long Term Debt	52.4M	54.2M	0.0	50.7M	58.3M	34.4M
Long Term Debt Total	55.3M	55.0M	56.3M	1.4M	1.7M	1.6M
Capital Surpluse	10.8M	12.1M	12.8M	18.8M	21.6M	12.7M

Pair Trading with Theratechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Theratechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theratechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theratechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theratechnologies to buy it.

The correlation of Theratechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theratechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theratechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Theratechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:

How To Invest In Theratechnologies

Details

Is Theratechnologies Stock a good investment?

Details

What is Theratechnologies' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.

You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theratechnologies Average Payables vs Price To Sales Ratio Analysis

Average Payables vs Price To Sales Ratio

Average Payables vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Average Payables

Price To Sales Ratio

Theratechnologies fundamental ratios Correlations

Theratechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theratechnologies fundamental ratios Accounts

Pair Trading with Theratechnologies

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Current Liab	+ 0.97	Total Liab
Cash And Short Term Investments	+ 0.95	Cash
Total Liab	+ 0.95	Net Receivables
Total Current Assets	+ 0.95	Total Liab
Accounts Payable	+ 0.94	Total Assets
Total Current Assets	+ 0.94	Total Assets

Other Current Liab	- 0.79	Retained Earnings
Other Assets	- 0.79	Total Stockholder Equity
Total Liab	- 0.76	Retained Earnings
Other Current Liab	- 0.75	Total Stockholder Equity
Other Assets	- 0.74	Retained Earnings
Retained Earnings	- 0.73	Net Debt